The Rs.331-crore Advanced Enzyme Technologies, the first Indian enzyme company, which went public in August last year has been faring quite well on the bourses. The firm’s stock has gained 54% from its listing price (split adjusted) of Rs.235.66 to the current levels of Rs.361. Over the same period, the benchmark Nifty Pharma Index had declined 21%. The company, whose promoter and managing director is Chandrakant Rathi, is among the top 15 global companies in terms of enzyme sales and has the second highest market share in India at around 30%.
Over the FY13-FY17, revenue has